The prostate cancer field is complex, and we need large and diverse teams to tackle the intricate issues from many perspectives. With that in mind, we are committed to supporting collaborative research and survivorship efforts. Examples of such projects include:


CPC-GENE is one of Canada’s contributions to the International Cancer Genome Consortium and links with other related prostate cancer activities around the world.
The research aims to identify genetic mutations in the genomes of prostate cancers, information that could be used to better detect tumours, determine tumour aggressiveness and identify the best treatment needed to personalize prostate cancer medicine for individual patients.

This is just one example of large-scale research programs that will make a difference in the field of prostate cancer research.

[Read more]


This project, funded by Safeway, is conducted by researchers at the Prostate Cancer Centre in Vancouver. The study aims to develop new treatments for prostate cancer when the tumour has spread and become hormone independent. Possible approaches include using computer technology for drug design, screening with a series of small molecules to find any that could potentially be effective drugs, and testing biological agents.


This national study looks at men who carry BRCA 1 and BRCA 2 genetic mutations, comparing those who have a family history of prostate cancer with patients who do not. The hypothesis is that patterns in the expression of proteins between these two groups could reveal important biomarkers in the diagnosis, prognosis and treatment of prostate cancer. The study is being led by a group of researchers in Toronto but involves collaborations with other researchers across Canada.

"Prostate cancer research is flourishing in Canada with important new work and discoveries taking place each year, which will no doubt help men everywhere with prostate cancer.” Dr. Robert Bristow, Pilot Grant recipient and head of BRCA1/2

Movember Team Grants

The new Movember Team Grants program provides funding to collaborative and innovative research teams in the field of prostate cancer. The program will facilitate collaboration between not only researchers but also institutions, providing an increasingly united approach to prostate cancer research. The opportunity unites researchers with the best minds in their shared fields from coast to coast.


Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
New test developed to detect men at high risk of prostate cancer recurrence

Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More

CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be

Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More

$1.8 Million awarded to Movember Rising Stars Supporting Innovators in Prostate Cancer Research

Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More

Support for Those Affected by Prostate Cancer

Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More

Click here for news archive